Stay updated on Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor patch with no changes to study content or user-facing features.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the older revision tag v3.4.1 and outdated government funding/status notices from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA government funding notice about potential delays and NIH operating status was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a Show glossary toggle, updated QC metadata (Last Update Submitted that Met QC Criteria) and a No FEAR Act Data footer note with revision v3.4.0; removed the older Last Update Submitted that met QC Criteria, No FEAR Act data, and revision v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.4 from v3.3.3; no substantive changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.